Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease
Masanori Shimizu, Kunihiro Suzuki, Kanako Kato, T. Jojima +7 more

